INTRINSIC HEPCIDIN IDX Trademark

Trademark Overview


On Monday, March 14, 2016, a trademark application was filed for INTRINSIC HEPCIDIN IDX with the United States Patent and Trademark Office. The USPTO has given the INTRINSIC HEPCIDIN IDX trademark a serial number of 86939579. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, July 1, 2024. This trademark is owned by Intrinsic LifeSciences LLC. The INTRINSIC HEPCIDIN IDX trademark is filed in the Chemical Products category with the following description:

assays for research purposes, namely, well plate enzyme linked immunosorbent assay (ELISA) for detection of human hepcidin for research and clinical use
intrinsic hepcidin idx

General Information


Serial Number86939579
Word MarkINTRINSIC HEPCIDIN IDX
Filing DateMonday, March 14, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, July 1, 2024
Registration Number5375901
Registration DateTuesday, January 9, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2017

Trademark Statements


Goods and Servicesassays for research purposes, namely, well plate enzyme linked immunosorbent assay (ELISA) for detection of human hepcidin for research and clinical use
NOT AVAILABLE"HEPCIDIN"

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, March 17, 2016
Primary Code001
First Use Anywhere DateWednesday, November 25, 2015
First Use In Commerce DateWednesday, November 25, 2015

Trademark Owner History


Party NameIntrinsic LifeSciences LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLa Jolla, CA 92037

Party NameIntrinsic LifeSciences LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLa Jolla, CA 92037

Party NameIntrinsic LifeSciences LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLa Jolla, CA 92037

Trademark Events


Event DateEvent Description
Thursday, June 23, 2016NON-FINAL ACTION WRITTEN
Thursday, March 17, 2016NEW APPLICATION ENTERED
Thursday, March 17, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 23, 2016ASSIGNED TO EXAMINER
Thursday, June 23, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 23, 2016NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 21, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 19, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, December 19, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, October 16, 2017TEAS STATEMENT OF USE RECEIVED
Monday, October 16, 2017USE AMENDMENT FILED
Monday, October 30, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 30, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 5, 2017ASSIGNED TO EXAMINER
Thursday, December 7, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 8, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, January 9, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, July 1, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 1, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, July 1, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED